JPRN-UMIN000042408已完成未知
Prospective clinical study of comprehensive genomic profiling for patients with chemotherapy-naive advanced cancer. - FIRST-Dx trial
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 182
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •Inappropriate for trial due to mental disease. Inappropriate for trial judged by medical doctors.
研究者
相似试验
尚未招募
不适用
Genomic evaluation in patients with diffuse large B cell lymphomaKCT0003963Samsung Medical Center200
Unknown
不适用
Real-world Clinical Effectiveness of Whole Genome and Transcriptome Analysis to Guide Advanced Cancer CareMetastatic CancerAdvanced CancerCancers That Cannot be Treated With Curative IntentNCT04141397British Columbia Cancer Agency1,200
招募中
不适用
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDSWhole Genome SequencingMyelodysplastic SyndromesAcute Myeloid LeukemiaNCT04986657Washington University School of Medicine325
招募中
不适用
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in MDSWhole Genome SequencingMyelodysplastic SyndromesNCT05434598Washington University School of Medicine60
进行中(未招募)
Unknown
The usefulness of whole genome sequencing in diagnosis and clinical management of drug-resistant tuberculosis patients in TanzaniaApplication of whole genome sequencing in multidrug resistance tuberculosis patientsInfections and InfestationsISRCTN14635089Tanzania Commission for Science and Technology153
